Page last updated: 2024-10-19

oxaloacetic acid and Acute Confusional Senile Dementia

oxaloacetic acid has been researched along with Acute Confusional Senile Dementia in 3 studies

Oxaloacetic Acid: A dicarboxylic acid ketone that is an important metabolic intermediate of the CITRIC ACID CYCLE. It can be converted to ASPARTIC ACID by ASPARTATE TRANSAMINASE.
oxaloacetic acid : An oxodicarboxylic acid that is succinic acid bearing a single oxo group.

Research Excerpts

ExcerptRelevanceReference
"Both doses were safe and tolerated."3.01Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients. ( Anderson, H; Becker, A; Bothwell, R; Brooks, W; Burns, JM; Choi, IY; Clutton, J; Harris, RA; Lee, P; Mahnken, JD; Mosconi, L; Pleen, J; Reed, G; Sherry, E; Swerdlow, RH; Vidoni, ED; Wilkins, HM; Zhang, N, 2021)
"In the case of Alzheimer's disease (AD), amyloid β (Aβ)-mediated disruption of synaptic plasticity and memory can be alleviated by interventions that directly remove glutamate or block certain glutamate receptors."1.46Peripheral Interventions Enhancing Brain Glutamate Homeostasis Relieve Amyloid β- and TNFα- Mediated Synaptic Plasticity Disruption in the Rat Hippocampus. ( Mably, AJ; Rowan, MJ; Walsh, DM; Zhang, D, 2017)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Vidoni, ED1
Choi, IY1
Lee, P1
Reed, G1
Zhang, N1
Pleen, J1
Mahnken, JD1
Clutton, J1
Becker, A1
Sherry, E1
Bothwell, R1
Anderson, H1
Harris, RA1
Brooks, W1
Wilkins, HM2
Mosconi, L1
Burns, JM1
Swerdlow, RH2
Zhang, D1
Mably, AJ1
Walsh, DM1
Rowan, MJ1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Anhydrous Enol-Oxaloacetate (AEO) on Improving Fatigue in Post-COVID-19 Survivors[NCT04592354]40 participants (Anticipated)Interventional2020-10-15Recruiting
A Randomized Double Blind Placebo Controlled Trial to Determine the Effects of Oxaloacetate on Improving Fatigue in ME/CFS[NCT05273372]80 participants (Anticipated)Interventional2022-03-15Enrolling by invitation
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for oxaloacetic acid and Acute Confusional Senile Dementia

ArticleYear
Relationships Between Mitochondria and Neuroinflammation: Implications for Alzheimer's Disease.
    Current topics in medicinal chemistry, 2016, Volume: 16, Issue:8

    Topics: Alzheimer Disease; DNA, Mitochondrial; Energy Metabolism; Exercise; Humans; Inflammation; Ketone Bod

2016

Trials

1 trial available for oxaloacetic acid and Acute Confusional Senile Dementia

ArticleYear
Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients.
    Alzheimer's & dementia : the journal of the Alzheimer's Association, 2021, Volume: 17, Issue:1

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognition; Dose-Response Relationship, Drug; Ener

2021
Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients.
    Alzheimer's & dementia : the journal of the Alzheimer's Association, 2021, Volume: 17, Issue:1

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognition; Dose-Response Relationship, Drug; Ener

2021
Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients.
    Alzheimer's & dementia : the journal of the Alzheimer's Association, 2021, Volume: 17, Issue:1

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognition; Dose-Response Relationship, Drug; Ener

2021
Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients.
    Alzheimer's & dementia : the journal of the Alzheimer's Association, 2021, Volume: 17, Issue:1

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognition; Dose-Response Relationship, Drug; Ener

2021

Other Studies

1 other study available for oxaloacetic acid and Acute Confusional Senile Dementia

ArticleYear
Peripheral Interventions Enhancing Brain Glutamate Homeostasis Relieve Amyloid β- and TNFα- Mediated Synaptic Plasticity Disruption in the Rat Hippocampus.
    Cerebral cortex (New York, N.Y. : 1991), 2017, 07-01, Volume: 27, Issue:7

    Topics: Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Animals; Aspartate Aminotransferase, Cy

2017